Kolon Corporation (KRX:002020)
South Korea · Delayed Price · Currency is KRW 20,150
+50 (0.25%)
Nov 4, 2026, 3:30 PM KST
Kolon Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 6,197,884 | 5,886,133 | 5,920,011 | 5,878,432 | 5,659,922 | 5,410,415 |
Revenue Growth | 4.51% | -0.57% | 0.71% | 3.86% | 4.61% | 10.64% |
Gross Profit Gross Profit Growth | 632,999 | 518,937 | 403,008 | 477,099 | 683,725 | 663,938 |
Operating Income Operating Income Growth | 105,892 | -49,958 | -90,941 | 121,022 | 316,207 | 326,324 |
Net Income Net Income Growth | -60,394 | -145,244 | 184,727 | 8,566 | 159,880 | 128,377 |
Earnings Per Share EPS Growth | -5434.32 | -11502.36 | 13265.94 | 625.15 | 11501.15 | 9210.27 |
EPS Growth | - | - | 2022.05% | -94.56% | 24.87% | -7.51% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Construction Business Construction Business Growth | 2,338,894 | 2,364,868 | 2,490,119 | 2,216,797 | 2,142,876 | 2,220,136 |
Manufacturing Division Manufacturing Division Growth | 119,648 | 102,022 | 39,464 | - | - | - |
Other Business Other Business Growth | 343,516 | 266,763 | 197,102 | 181,643 | 159,494 | 147,134 |
IT Business IT Business Growth | 742,600 | 548,147 | 505,977 | 533,452 | 492,642 | 428,512 |
Adjust and Remove Adjust and Remove Growth | -107,938 | -126,253 | -93,718 | -78,913 | -86,267 | -79,242 |
Holding Business Holding Business Growth | 144,874 | 102,582 | 74,096 | 70,189 | 108,236 | 109,379 |
Distribution Business Distribution Business Growth | 2,616,291 | 2,628,004 | 2,668,580 | 2,820,244 | 2,735,146 | 2,486,264 |
Pharmaceutical Business Pharmaceutical Business Growth | - | - | 38,390 | 135,019 | 107,795 | 98,232 |
Total Total Growth | 6,197,884 | 5,886,133 | 5,920,011 | 5,878,432 | 5,659,922 | 5,410,415 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 361,524 | 428,573 | 489,965 | 365,681 | 455,779 | 235,146 |
Total Debt Total Debt Growth | 2,705,540 | 2,626,604 | 2,631,278 | 2,278,059 | 1,819,967 | 1,529,280 |
Net Cash (Debt) Net Cash Growth | -2,344,016 | -2,198,032 | -2,141,313 | -1,912,378 | -1,364,188 | -1,294,134 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -168701.76 | -157099.33 | -155999.33 | -138702.98 | -98134.53 | -92846.03 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -75,819 | 10,407 | -179,714 | -106,501 | 239,093 | 223,933 |
Capital Expenditures CapEx Growth | -116,099 | -87,331 | -112,126 | -234,794 | -53,474 | -39,734 |
Free Cash Flow Free Cash Flow Growth | -191,918 | -76,924 | -291,840 | -341,296 | 185,620 | 184,199 |
Free Cash Flow Growth | - | - | - | - | 0.77% | -40.46% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 10.21% | 8.82% | 6.81% | 8.12% | 12.08% | 12.27% |
Operating Margin | 1.71% | -0.85% | -1.54% | 2.06% | 5.59% | 6.03% |
Pretax Margin | -3.42% | -6.31% | 3.94% | 0.38% | 5.07% | 4.48% |
Profit Margin | -0.97% | -2.47% | 3.12% | 0.15% | 2.83% | 2.37% |
FCF Margin | -3.10% | -1.31% | -4.93% | -5.81% | 3.28% | 3.40% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 550.000 | 550.000 | 600.000 | 550.000 | 550.000 | 550.000 |
Dividend Per Share Growth | 0% | -8.33% | 9.09% | 0% | 0% | - |
Dividend Yield | 2.73% | 1.07% | 4.31% | 3.21% | 2.56% | 1.58% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 4, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 1.03 | 27.38 | 1.84 | 3.43 |
Forward PE | 3.23 | 6.81 | 6.81 | 6.81 | 6.81 | 6.81 |
P/FCF Ratio | - | - | - | - | 1.59 | 2.39 |
PS Ratio | 0.04 | 0.11 | 0.03 | 0.04 | 0.05 | 0.08 |